Pharma

By Jonah Comstock May 20, 2015
Swedish clinical trial recruitment company Trialbee has raised $5 million in first-round funding from existing investors Industrifonden and Briban Invest. The company previously raised about $3.2 million in seed funding. The money will be used, among other things, to support Trialbee's entrance into the US market. Trialbee provides mobile and web-based tools for clinical trial recruitment, online...
By Brian Dolan May 14, 2015
During Everyday Health's first quarter earnings call this week, CEO and Co-founder Ben Wolin pointed to strong growth in mobile marketing revenues for the health media company. Everyday posted a $8.1 million loss on total Q1 revenue of $41.2 million, which is up 10 percent over Q1 2014. Mobile revenues grew 35 percent year-over-year, according to the company, and accounted for 38 percent of...
By Jonah Comstock May 13, 2015
Iodine, the crowdsourced medication review company run by former Wired editor Thomas Goetz and former Google engineer Matt Mohebbi, is launching a new study this month to look specifically at the effects of antidepressants. The study, called Iodine Timeline, will guide anti-depressant users to give feedback for one month about their treatment by opting into short, regular survey questions by...
By Jonah Comstock May 12, 2015
Pharma-related digital health news picked up this week. Boehringer Ingelheim has teamed up with Sutter Health to research COPD interventions; BioDelivery Science created an app to help users deal with prediction opioid addictions; and Canaan Partners' Julie Papanek talked to the Wall Street Journal about pharma's emerging role in digital health. Boehringer Ingelheim Pharmaceuticals, the...
By Aditi Pai May 11, 2015
A recent study published in the BMC Medicine medical journal concluded that smartphone apps that offer an insulin dose calculator may actively contribute to incorrect dose recommendations, according to the systematic assessment of 46 insulin dose calculator apps available on iOS and Android in the UK App Store. Apps data was collected in August 2013. Researchers explained in the abstract that...
By Jonah Comstock May 6, 2015
Indianapolis-based pharma giant Eli Lilly is opening a new drug delivery and innovation center in Kendall Square in Cambridge, Massachusetts. Construction will begin immediately, with the center opening by the end of the year for a planned staff of 30 scientists and engineers. Eli Lilly Senior Director of Global Corporate Communications Edward Sagebiel said one Eli Lilly executive will move to...
By Jonah Comstock May 4, 2015
Johnson & Johnson company LifeScan is launching a clinical trial to determine whether its OneTouch Verio blood glucose meter (or a not-yet-launched version of it) creates a greater reduction in A1C levels when used in conjunction with its companion app. According to a post on ClinicalTrials.gov, the company is recruiting 148 patients for a randomized control trial that will compare patients...
By Aditi Pai April 30, 2015
A majority of consumers are willing to take greater ownership of their health, according to a survey of 2,024 US adults and 516 primary care physicians. The survey was conducted by Ipsos in collaboration with the National Council on Patient Information and Education (NCPIE) and Pfizer. The survey found that 64 percent of respondents said they could be making more decisions about their health and...
By Aditi Pai April 16, 2015
New Jersey's Division of Consumer Affairs has launched a new app for iPhones that will allow authorized users of the state’s prescription monitoring program, prescribers and pharmacists licensed in New Jersey, access to the database via their smartphone. The database is managed by the New Jersey Prescription Management Program (NJPMP), a program under the Division of Consumer Affairs. The NJPMP...
By Jonah Comstock April 15, 2015
Boston-based patient network PatientsLikeMe announced two pieces of pharma news this week: a five-year research collaboration deal with AstraZeneca and the results of a multiple sclerosis wearable study conducted in collaboration with Biogen. The PatientsLikeMe-AstraZeneca deal is similar to one the company struck with Genentech last Spring. AstraZeneca will have full access to PatientsLikeMe's...